MedTrace Logo

Proof-of-Concept Study to Determine the Flow Changes When Stimulating Two Neural Targets for the Treatment of Obstructive Sleep Apnea

NCT06415981 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2024-05-16

No results posted yet for this study

Summary

This proof-of-concept study will evaluate the impact of surgically placing and stimulating the hypoglossal nerve and/or a second neural target Ansa Cervicalis, with a set of off-the-shelf electrode arrays.

Conditions

  • Sleep Apnea
  • Sleep Apnea, Obstructive
  • Sleep Disorder
  • Sleep Apnea Syndromes

Interventions

DEVICE

Hypoglossal nerve and/or Ansa Cervicalis stimulation

Device stimulation of the hypoglossal nerve and/or Ansa Cervicalis

Sponsors & Collaborators

  • University College London Hospitals

    collaborator OTHER

  • Invicta Medical Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-21
Primary Completion
2024-06-30
Completion
2024-07-31
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06415981 on ClinicalTrials.gov